Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 16, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Hematologic Malignancy
Interventions
BIOLOGICAL

Transplantation of cord blood expanded with UM171

Myeloablative or submyeloablative conditioning regimen followed by an expanded cord blood transplant

Trial Locations (1)

H1T2M4

Hopital Maisonneuve-Rosemont, Montreal

All Listed Sponsors
collaborator

Canadian Cancer Society (CCS)

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Hopital de l'Enfant-Jesus

OTHER

collaborator

Vancouver General Hospital

OTHER

collaborator

St. Justine's Hospital

OTHER

collaborator

Stem Cell Network

OTHER

lead

Maisonneuve-Rosemont Hospital

OTHER

NCT02668315 - Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant | Biotech Hunter | Biotech Hunter